NIH-funded research R01 grant

Reducing the sale of marijuana to intoxicated customers

Official title: Policy and Training Intervention in Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers

Funded at Klein Buendel, INC. · NIH-10932385 · Data updated 2026-11-12

This study is looking at ways to help marijuana stores in Oregon make sure they don’t sell to people who are already high, by training staff to spot signs of intoxication and follow the rules, so everyone stays safe and responsible.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionKlein Buendel, INC.
NIH-funded
Lab location1 site (Golden, United States)
Project startSeptember 20, 2023
Project endAugust 31, 2027
Funding year2024
Award (this year)$668,254
NIH project number5R01AA031591-02
Project IDNIH-10932385 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who frequent recreational marijuana dispensaries and may be affected by policies regarding intoxicated sales.

Less likely to help

Patients who do not consume marijuana or are not involved in recreational marijuana markets may not benefit from this research.

What this research studies

This research investigates how to prevent the sale of marijuana to customers who are already intoxicated, particularly in the context of new recreational marijuana markets. It focuses on implementing a policy and training intervention in Oregon, where laws prohibit selling to obviously intoxicated individuals. The approach includes training store personnel to recognize signs of intoxication and comply with state regulations, alongside efforts to enhance enforcement of these laws. The study will assess the effectiveness of these interventions through evaluations at various marijuana retail locations.

Why it matters

Potential benefit: If successful, this research could lead to safer marijuana sales practices and reduce incidents of impaired driving and related harms.

How similar studies have gone: While this approach is innovative, similar interventions targeting responsible sales practices in alcohol and other substances have shown promise in reducing related harms.

Where this research is happening

  • Klein Buendel, INC.
    Golden, United States
    Active

Researchers

  • Principal investigator: Woodall, W Gill — Klein Buendel, INC.
  • Study coordinator: Woodall, W Gill

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.